• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in
Truveta experts: Biomarker testing trends in metastatic non-small cell lung cancer (NSCLC)

Truveta experts: Biomarker testing trends in metastatic non-small cell lung cancer (NSCLC)

by Truveta staff | Aug 28, 2025 | Research

Biomarker testing has transformed cancer care over the past decade, opening the door to targeted therapies that can improve outcomes for patients with advanced disease. Yet despite strong guideline recommendations, many patients with metastatic non-small cell lung...

Share this


Recent posts

  • Impact of the CVS GLP-1 formulary change: Trends in switching
  • Impact of the CVS GLP-1 formulary change: Trends in prescribing
  • One-year cardiovascular outcomes after GLP-1 discontinuation

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Solutions

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2025

Our website uses cookies to ensure you have the best experience.